Vericiguat improves cardiac remodelling and function in rats with doxorubicinâinduced cardiomyopathy
Sign Up to like & getrecommendations! Published in 2025 at "ESC Heart Failure"
DOI: 10.1002/ehf2.15186
Abstract: Vericiguat, a soluble guanylate cyclase (sGC) stimulator, has been demonstrated effective in improving prognosis of patients with heart failure with reduced ejection fraction. However, there are limited data concerning the effect of vericiguat in patients… read more here.
Keywords: improves cardiac; function rats; vericiguat improves; vericiguat ... See more keywords